COMEDK UGET 2023: The Consortium of Medical, Engineering, and Dental Colleges of Karnataka has released the COMEDK UGET 2022 Round 3 Seat Allotment Results. Candidates who have applied for the COMEDK UGET 2022 Admission Counselling Process can visit the official website of COMEDK to check the allotment results.
As per the given schedule, the decision-making and fee payment based on the COMEDK UGET 2022 Round 3 Allotment begins today and will continue until November 16, 2022. Candidates allotted seats per their preference can report to the allotted colleges between November 14 and 17, 2022.
COMEDK UGET 2022 Round 3 Seat Allotment Result is available on the official website - comedk.org. Candidates can also click on the direct link given here to check the COMEDK UGET 2022 Seat Allotment Result.
COMEDK UGET 2022 Round 3 Allotment - Click Here
Steps to check COMEDK UGET Round 3 Allotment Results
The COMEDK UGET 2022 Seat Allotment Result for Round 3 is available in the candidate login link. To check the allotment result candidates can visit the official website and login using the Application Number and Password. Candidates can also follow the steps given below to check the COMEDK UGET 2022 Round 3 Allotment.
Step 1: Visit the COMEDK UGET official website
Step 2: Click on the Engineering Login
Step 3: Enter the COMEDK UGET 2022 Application Number and Password
Step 4: Download the COMEDK UGET allotment result and allotment letter for admissions
COMEDK UGET 2022 allotment results have been released based on the ranks secured and the preferences entered by students in the choice-filling process. Candidates also need to carry with them their original documents and photocopies of the documents.
Related Stories
Documents to be submitted
When reporting to the colleges, candidates must carry the following documents with then
- COMEDK UGET scorecard
- UGET TAT with Signature
- COMEDK Verification Entry Card
- Original ID Proof
- Fee Payment Receipt
- Parents/ Guardian's Original ID proof
- Category certificates
Comments
All Comments (0)
Join the conversation